Antagonism of substance P and perception of dyspnea in patients with COPD

D. Mahler, A. Gifford, L. Waterman, A. Gilani, B. Kupchak, W. Kraemer (Lebanon, Storrs, United States Of America)

Source: Annual Congress 2013 –COPD mechanisms
Session: COPD mechanisms
Session type: Thematic Poster Session
Number: 2146
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Mahler, A. Gifford, L. Waterman, A. Gilani, B. Kupchak, W. Kraemer (Lebanon, Storrs, United States Of America). Antagonism of substance P and perception of dyspnea in patients with COPD. Eur Respir J 2013; 42: Suppl. 57, 2146

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Breathlessness perception in COPD: Relationship with exacerbation frequency
Source: International Congress 2015 – Multidimensional analysis of respiratory problems
Year: 2015


Glycopyrronium significantly improves lung function, dyspnea and health status in COPD patients in all GOLD groups
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015

Small airway obstruction involvement in COPD severity
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013


Gender differences in COPD patients
Source: International Congress 2014 – Clinical presentations
Year: 2014

Descriptors of exertional dyspnea across the COPD severity spectrum
Source: International Congress 2016 – Unmasking the mechanisms of symptoms and exercise limitation in disease
Year: 2016

Night time dyspnea in COPD: A study of a general population
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013


Air trapping is associated with exercise capacity in persons without overt obstructive lung disease
Source: International Congress 2016 – Mechanisms of symptoms and exercise limitation in health and disease
Year: 2016


Readmissions in COPD: The perspective of the patient
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016


Inter-relationship of different types of respiratory symptoms in COPD
Source: International Congress 2014 – Comorbidities
Year: 2014

Lung function in never smoking patients with alpha1antitrypsin deficiency
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013

Symptom profile of exacerbations in earlier and later COPD
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013


COPD and depression: Prevalence and interaction
Source: International Congress 2014 – Comorbidities
Year: 2014


Relationship between dyspnea and depression in the elderly patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD: points to ponder
Year: 2014

Clinical Impact of Gensini score in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016

Integrated care reduces hospital utilization among patients with severe COPD
Source: International Congress 2014 – COPD exacerbations
Year: 2014

Exploring the association between psychological distress and dyspnea in COPD
Source: International Congress 2016 – Best abstracts in COPD management
Year: 2016


COPD: Influence of patients’ nutritive status on the exacerbations rate
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016

The severity of anxiety in COPD patients (pts)
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016


Determinants of severity of dyspnea in COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013


Do COPD patients with only mild-to-moderate airflow obstruction present with endothelial dysfunction?
Source: International Congress 2016 – From cardiopulmonary interaction to locomotor muscles and dyspnoea in health and disease
Year: 2016